19results about How to "Lower triglycerides" patented technology

The invention provides a probiotics plant solid beverage for treating hyperuricemia and gout. The solid beverage is prepared by mixing freeze-dried probiotics powder and plant extract with the addition of proper auxiliary materials. The solid beverage comprises the following components: the plant extract, the auxiliary materials and the probiotics, with the sum of the mass percentage of each component being 100%. The plant extract comprises celery seed powder, sophora flower bud powder and platycodon root powder. The invention has an obvious effect on lowering uric acid and relieving gout.

The invention discloses a strain of bifidobacterium animalis dipro-60 and a preparation method thereof. The invention further discloses a preparation, and the preparation contains the bifidobacterium animalis dipro-60. The bifidobacterium animalis dipro-60 used in the invention has the ability of producing bile salt hydrolase BSH, the ability of reducing cholesterol, the ability of inhibiting helicobacter pylori and the ability of reducing inflammatory factor TNF-alpha; further animal experiments show that the dipro-60 can improve lipid metabolism related diseases, can significantly reduce weight gain of obese mice induced by high fat, significantly reduce the liver weight of the obese mice, reduce the content of triglyceride and blood sugar in blood, improve intestinal barriers and improve the lipid metabolism related diseases, and the dipro-60 can improve the lipid metabolism related diseases. Liver lipid accumulation caused by obesity or hyperlipidemia is improved, and bone loss caused by obesity or hyperlipidemia is improved.

The invention discloses a system and a preparation process for stewing seafood sauce, and belongs to the technical field of food processing. The system for stewing seafood sauce provided by the invention comprises a first production line, a second production line and a third production line. The preparation process for stewing seafood sauce provided by the invention comprises the following steps: raw material cleaning, drying, shearing and crushing, pressing into cakes, frying, cooling, enzymolysis, filtering, evaporation and concentration, and mixing with refined extracts of fish oil and shrimp oil and seasonings, which solves the problem of heavy fishy smell and bitter taste in the prior art, and obtains seafood sauce with strong seafood flavor, natural, sweet and aftertaste, and the addition of shrimp oil and fish oil makes the seafood sauce more nutritious on the basis of freshness and seasoning.

The invention provides lactobacillus reuteri LR-XR23 and application of the lactobacillus reuteri LR-XR23 in treatment and / or improvement of NAFLD, and relates to the technical field of microorganisms and the technical field of biological medicine. According to the invention, lactobacillus reuteri LR-XR23 is successfully separated from the colon of a NAFLD model mouse induced by a high-fat feed after being treated by traditional Chinese medicine coix seed essential oil, and the preservation number is GDMCC 65010. The strain can significantly reduce the weight of a high-fat feed induced NAFLD model mouse and inhibit the formation of fat; the hyperlipidemia symptom of a high-fat feed induced NAFLD model mouse is improved, and the function of regulating lipid metabolism is achieved; meanwhile, the lactobacillus reuteri LR-XR23 can be colonized in intestinal tracts, so that the diversity of intestinal flora is increased, and the ecological balance of the intestinal tracts is restored. The lactobacillus reuteri LR-XR23 provided by the invention provides a new thought and method for improving and / or treating the NAFLD.

The invention relates to the field of feed additives, and discloses a folium cortex eucommiae compound feed additive and a preparation method thereof, and the folium cortex eucommiae compound feed additive comprises the following components in parts by weight: 60-90 parts of fermented folium cortex eucommiae powder, 10-20 parts of cortex eucommiae seed meal, 1-5 parts of a traditional Chinese medicine extract, 2-10 parts of a microbial preparation, 5-10 parts of charcoal modified montmorillonite and 2-10 parts of a yeast cell wall extract. The folium cortex eucommiae compound feed additive is prepared by mixing the fermented folium cortex eucommiae with high-activity component content, the treated folium cortex eucommiae seed meal, the traditional Chinese medicine extract, the biochar modified montmorillonite and the yeast cell wall extract, and the folium cortex eucommiae compound feed additive prepared by the method has high-activity components; and under the condition that antibiotics and vaccines are not used, the production performance of the laying hens can be improved, the laying rate of the laying hens is increased, the soft and broken egg rate is reduced, animal health is maintained, the content of total cholesterol, triglyceride and low-density lipoprotein in blood is reduced, the content of high-density lipoprotein is increased, and the death rate of the laying hens is reduced.

The present invention belongs to the field of microbial technology, and specifically relates to a fermented lactobacillus and its application in a preparation for improving hyperlipidemia. The strain is deposited in the General Microbiology Center of the China Microbiological Culture Collection Administration Committee, and the deposit number is CGMCC No. 25738. The cholesterol removal rate of the strain is as high as 55.2%, and it can significantly reduce the levels of triglycerides, cholesterol and low-density lipoprotein in the body's serum, and promote the secretion of short-chain fatty acids in the intestine, significantly improve the pathological condition of mouse liver, thereby effectively improving hyperlipidemia; and it has no side effects and high safety.

This invention discloses an oil composition with a balanced fatty acid ratio and lipid-lowering effects, and its applications. The oil composition comprises vegetable oil, probiotics, phospholipids from camellia seed cake, gelatin, and sodium alginate. It effectively reduces serum triglyceride, total cholesterol, and low-density lipoprotein cholesterol levels while increasing high-density lipoprotein cholesterol levels, exhibiting a good lipid-lowering effect. Furthermore, when the oil composition is formulated into microcapsules, it exhibits good stability, encapsulation efficiency, and release rate. The oil composition also helps maintain the activity of probiotics, allowing for better preservation and efficacy. Based on this, this invention also provides a candy containing the oil composition, enriching the variety of products with lipid-lowering effects and promoting the development of lipid-lowering related products.

The invention discloses a flaxseed composition capable of reducing triglyceride and facilitating obesity prevention and a preparation method of the flaxseed composition, and relates to the field of chemistry. According to the flaxseed composition capable of reducing triglyceride and contributing to obesity prevention and the preparation method of the flaxseed composition, the composition consists of the following components: 30-90% of flaxseeds; 10%-40% of tartary buckwheat; 0%-50% of oligosaccharide; the preparation method comprises the following steps: mixing the flaxseeds, the tartary buckwheat and the oligosaccharide according to the proportion in claim 1; crushing and screening to ensure that all the components are fully and uniformly mixed; and drying the mixture to obtain a final product. According to the composition, by reducing the triglyceride level, the risk of cardiovascular diseases is effectively reduced, and the overall metabolic state is improved; by promoting fat oxidation and improving insulin sensitivity, normal blood glucose and lipid levels can be maintained; the composition is helpful for reducing body weight and preventing obesity by regulating energy metabolism, reducing appetite and improving intestinal microbial environment.

The invention discloses mushroom and lucid ganoderma wine and a brewing method thereof.The mushroom and lucid ganoderma wine is prepared from 260-300 kg of rice wine, 430-470 kg of distilled liquor, 6-12 kg of mushrooms, 1-5 kg of lucid ganoderma, 2-7 kg of milkvetch roots, 2-7 kg of Chinese wolfberry fruits, 1-5 kg of mulberries, 6-12 kg of cistanche deserticola and 250-300 kg of cold boiled water according to 1000 kg of finished products. The lentinus edodes and lucid ganoderma wine brewed by the method integrates the effects of various medicinal and edible food materials such as the sticky rice, the lentinus edodes, the lucid ganoderma and the astragalus membranaceus, and has relatively high nutritional and medicinal values; the effects of resisting cancer, enhancing human immunity, tonifying qi, soothing the nerves, relieving cough and asthma, supporting healthy energy, protecting the liver, resisting fatigue, delaying senescence, reducing blood sugar, promoting circulation, expanding blood vessels, reducing blood cholesterol and triglyceride and the like can be achieved.

The present invention belongs to the technical field of Chinese medicine preparation, and specifically relates to a Chinese medicine composition for treating hypertension or hypertension combined with hyperlipidemia and a preparation method thereof. The Chinese medicine composition for treating hypertension or hypertension combined with hyperlipidemia of the present invention is composed of the following raw materials in parts by weight: 8-20 parts of stinking knotweed, 8-20 parts of polyphemus, 1-5 parts of astragalus, 1-5 parts of mistletoe, 3-6 parts of siler, 1-5 parts of glossy privet, 1-5 parts of oriental rhizome, 1-2 parts of eucommia bark, 1-2 parts of ligusticum, 1-2 parts of ligusticum, 1-2 parts of chuanxiong, and 1-2 parts of earthworm. The Chinese medicine composition of the present invention has good antihypertensive and lipid-lowering effects, can effectively treat hypertension, has little side effects, and is particularly suitable for hypertension combined with hyperlipidemia.

The invention discloses application of a traditional Chinese medicine composition in preparation of lipid-lowering and liver-protecting medicines. The traditional Chinese medicine composition is prepared from pseudo-ginseng and red yeast rice. Researches find that by compounding the pseudo-ginseng and the red yeast rice, the lipid-lowering effect can be remarkably improved, cholesterol, triglyceride and low-density lipoprotein of a patient are reduced, and meanwhile, the influence of the red yeast rice on the liver function is also relieved. Compared with the prior art, the GGT, ALP and TBIL levels of patients are basically unchanged. Therefore, the traditional Chinese medicine composition provided by the invention has the effects of lowering lipid, protecting the liver, activating blood, removing turbidity and resisting atherosclerosis, can be used for treating patients with hyperlipidemia, and has a wide application prospect in clinical guidance of medication.

The present application relates to a kind of feed additive for improving fatty liver of post- laying hen and its preparation method and application method, belong to livestock and poultry feed processing technical field.For the single component additive effect of post- laying hen fatty liver is limited, and lack of the plant combination with synergistic effect screened from local characteristic plant resources.The feed additive provided by the present application comprises the ethanol extract of the mixture of small Xianggou root, tea leaf piece and San Ye Qing tuber, and the weight ratio of small Xianggou root, tea leaf piece and San Ye Qing tuber is (4.0-4.2) : (3.3-3.4) : 2.6.The additive can systematically improve the liver lipid metabolism of post- laying hen, reduce the triglyceride and total cholesterol levels in liver and serum, relieve fatty liver hemorrhagic syndrome, and improve egg production rate and egg quality.The additive is mainly used for post- laying hen feed to improve liver health and maintain production performance.

The invention relates to a preparation method of a soft capsule for regulating blood fat and preventing atherosclerosis, the soft capsule comprises a soft capsule content and a soft capsule shell, and the mass ratio of the soft capsule content to the soft capsule shell is (0.9-1.7): 1; wherein the soft capsule content comprises a traditional Chinese medicine composition, a diluent and a suspending aid, and the mass ratio of the traditional Chinese medicine composition to the sum of the diluent and the suspending aid is 1: (1.30-1.60); the traditional Chinese medicine composition comprises red yeast rice, a grape seed extract and a ginkgo leaf extract according to a mass ratio of (170-200): (70-100): (15-35). The soft capsule skin is prepared from water, gelatin and glycerol in a mass ratio of (0.7-1.2): 1: (0.3-0.7); the soft capsule content and the capsule skin glue solution are pressed into pills by a pill pressing machine. The soft capsule has the effects of regulating blood fat and preventing atherosclerosis, also has economical efficiency and stability, and solves the technical problems of long disintegration time limit, adhesion, oil leakage, bubbles and aging of the soft capsule.

The present invention relates to a novel pyrazine structure FXR agonist, a preparation method and application thereof, and specifically to a compound of the following general formula, a hydrate, a solvate, a pharmaceutically acceptable salt or a single isomer thereof, which has the effect of treating non-alcoholic fatty liver disease.

The invention relates to the technical field of edible oil, and provides a camellia oil compound composition with a lipid-lowering function. The camellia oil compound composition provided by the invention comprises camellia oil, linseed oil and perilla oil. The camellia oil contains rich unsaturated fatty acid, oleic acid and linoleic acid, the flaxseed oil and the perilla oil contain a large amount of alpha-linolenic acid, and the camellia oil, the flaxseed oil and the perilla oil are compounded to obtain the compound composition which is rich in nutritional ingredients and has a good lipid-lowering effect; the compound composition can achieve the health-care function of lowering lipid while meeting the requirement of a human body for grease nutrition, and has a wide market prospect.

The present invention relates to the technical field of red yeast rice products, and in particular to a tablet-type red yeast rice product and a preparation method thereof. The preparation method includes: weighing red yeast rice, hawthorn, peach kernel, turmeric, lotus leaf, clove and cinnamon; crushing to obtain a mixture; heating and stirring the mixture with water to obtain a mixture; sterilizing the mixture, cooling, inoculating fermentation bacteria, obtaining a pre-fermented liquid, then fermenting, sterilizing, and obtaining a sterilized material; coarsely filtering the sterilized material, and then filtering with an ultrafiltration membrane having a molecular weight cutoff not higher than 1.5KDa to obtain a filtrate, the filtrate is dried to obtain an extract; the extract, resistant dextrin, hydroxymethyl cellulose, sorbitol and magnesium stearate are tableted to obtain the tablet-type red yeast rice product. The tablet-type red yeast rice product of the present invention has excellent effects on reducing the content of triglycerides TG, total cholesterol CHO, low-density lipoprotein LDL and inflammatory factor I CAM-1 in serum, and has the effect of preventing or treating vascular sclerosis.

The invention provides application of typhaenoside and / or an active metabolite thereof in preparation of a medicine for preventing and / or treating hyperlipidemia, and belongs to the technical field of medicines. The invention also provides application of the cattail new glycoside and / or active metabolites thereof and pharmaceutically acceptable salts, hydrates, solvates, enantiomers, stereoisomers and tautomers thereof in preparation of drugs for prevention and / or treatment of hyperlipidemia, wherein the active metabolites and the pharmaceutically acceptable salts, hydrates, solvates, enantiomers, stereoisomers and tautomers of the cattail new glycoside are provided. The cattail new glycoside or the active metabolite of the cattail new glycoside can obviously reduce the levels of triglyceride, total cholesterol, low-density lipoprotein cholesterol and fasting blood-glucose in blood of an ob / ob hyperlipemia mouse, and meanwhile, the hypertrophy of adipocytes in epididymis white adipose tissues caused by hyperlipemia is obviously improved. As a medicine for reducing blood fat and treating hyperlipidemia, the typha orientalis glucoside or the active metabolite of the typha orientalis glucoside has a huge market application prospect.

The invention belongs to the technical field of cardiovascular diseases, and discloses a bacillus natto health-care food formula and a preparation process thereof, the bacillus natto health-care food formula comprises raw materials and auxiliary materials, the raw materials comprise freeze-dried natto powder, ginkgo biloba extract and salvia miltiorrhiza extract, and the auxiliary materials comprise soybean oil, gelatin, purified water, glycerin, beeswax, titanium dioxide and caramel color. According to the invention, the natto powder, the ginkgo biloba extract and the salvia miltiorrhiza extract are matched according to the mass ratio of 2: 1: 0.52, and the natto powder, the ginkgo biloba extract and the salvia miltiorrhiza extract all have the efficacy of reducing blood fat, and have obvious effects on reducing endogenous cholesterol and triglyceride; low-density lipoprotein can be reduced, the content of high-density lipoprotein can be increased, and a good blood fat reduction assisting effect is achieved. The three raw materials have no incompatibility, have a synergistic effect, can better regulate the TC, TG, LDL-C and HDL-C levels of hyperlipemia, reduce the blood fat level and reduce the morbidity of coronary heart disease and hypertension, and are beneficial to actual application and operation.

The application provides an effect and application of CREPT in fatty liver disease and complications thereof, in particular, application of CREPT gene or protein as a target or a reagent for targeting the CREPT gene or protein in treatment of metabolic-related fatty liver disease and fatty liver disease complications or in preparation of a medicine for treating metabolic-related fatty liver disease and fatty liver disease complications, and the metabolic-related fatty liver disease and fatty liver disease complications are treated by reducing the expression of the CREPT gene or reducing the function or inactivating the CREPT protein. The present application firstly finds that the CREPT is closely related to the metabolic-related fatty liver disease: the systemic or local medication can effectively treat the metabolic-related fatty liver disease and fatty liver disease complications by reducing the expression of the CREPT.